Related references
Note: Only part of the references are listed.Pharmacological Interventions to Attenuate Alzheimer's Disease Progression: The Story So Far
Firas H. Bazzari et al.
CURRENT ALZHEIMER RESEARCH (2019)
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome
Siamak MahmoudianDehkordi et al.
ALZHEIMERS & DEMENTIA (2019)
Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR- and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet
Fan Zheng et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Effect of Aluminum Exposure on Glucose Metabolism and Its Mechanism in Rats
Xi Wei et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2018)
Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis
P. Barton Duell et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Attenuation of Aluminum Chloride-Induced Neuroinflammation and Caspase Activation Through the AKT/GSK-3 beta Pathway by Hesperidin in Wistar Rats
Arokiasamy Justin-Thenmozhi et al.
NEUROTOXICITY RESEARCH (2018)
Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
Christian Benedict et al.
FRONTIERS IN NEUROSCIENCE (2018)
Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis
Suchun Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Synergistic Effect of Quercetin and α-Lipoic Acid on Aluminium Chloride Induced Neurotoxicity in Rats
Sooad Saud Al-Otaibi et al.
JOURNAL OF TOXICOLOGY (2018)
Neuroprotective Effect of Nanodiamond in Alzheimer's Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 Signaling
Shawqi H. Alawdi et al.
MOLECULAR NEUROBIOLOGY (2017)
Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism
Preeti Pathak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)
Gerald Salen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Effect of insulin on spatial memory in aluminum chloride-induced dementia in rats
Madhavan Nampoothiri et al.
NEUROREPORT (2017)
Insulin Resistance Disrupts the Interaction Between AKT and the NMDA Receptor and the Inactivation of the CaMKIV/CREB Pathway in Minimal Hepatic Encephalopathy
Saidan Ding et al.
TOXICOLOGICAL SCIENCES (2017)
Overexpression of matrix metalloproteinase-9 (MMP9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer's disease
Archontia Kaminari et al.
SCIENTIFIC REPORTS (2017)
Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/RNS generation
Waqar Ahmad et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass
Signe Nielsen et al.
PHYSIOLOGICAL REPORTS (2017)
Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion
M. Hansen et al.
DIABETES OBESITY & METABOLISM (2016)
Effect of low frequency stimulation on impaired spontaneous alternation behavior of kindled rats in Y-maze test
Samireh Ghafouri et al.
EPILEPSY RESEARCH (2016)
Identification of functional farnesoid X receptors in brain neurons
Chao Huang et al.
FEBS LETTERS (2016)
Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model
Hong-Mei Zhang et al.
MOLECULAR MEDICINE REPORTS (2016)
The bile acid chenodeoxycholic acid directly modulates metabolic pathways in white adipose tissue in vitro: insight into how bile acids decrease obesity
Joao Soeiro Teodoro et al.
NMR IN BIOMEDICINE (2016)
Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist
Kenichi Katsurada et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Bile Acids in Neurodegenerative Disorders
Hayley D. Ackerman et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults-Results from the Cross-Sectional KarMeN Study
Lara Frommherz et al.
PLOS ONE (2016)
Brain-Derived Neurotrophic Factor Serum Levels and Hippocampal Volume in Mild Cognitive Impairment and Dementia due to Alzheimer Disease
Ericksen Mielle Borba et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2016)
Brain-derived neurotrophic factor and its clinical implications
Siresha Bathina et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors
Cheryl A. Brighton et al.
ENDOCRINOLOGY (2015)
Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance
Mohamed Sham Shihabudeen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Sungsoon Fang et al.
NATURE MEDICINE (2015)
Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression
Thiruchelvam Kariharan et al.
NEUROBIOLOGY OF AGING (2015)
Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction
Qiong Xiang et al.
NEUROPEPTIDES (2015)
Aberrant insulin signaling in Alzheimer's disease: current knowledge
Gaurav Bedse et al.
FRONTIERS IN NEUROSCIENCE (2015)
Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome
Bhumsoo Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies
Mark Yarchoan et al.
ACTA NEUROPATHOLOGICA (2014)
Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride
Salvatore Giunta et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells
Xiao-Min Xin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice
Rita M. Ramalho et al.
NEUROBIOLOGY OF AGING (2013)
Protective effects of copper against aluminum toxicity on acetylcholinesterase and catecholamine contents of different regions of rat's brain
Ali Asghar Moshtaghie et al.
NEUROLOGICAL SCIENCES (2013)
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
Yongjie Ma et al.
PHARMACEUTICAL RESEARCH (2013)
Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales
Ian Clark et al.
PHARMACOLOGICAL REVIEWS (2012)
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Anita E. Autry et al.
PHARMACOLOGICAL REVIEWS (2012)
Exercise Increases Insulin Signaling in the Hippocampus: Physiological Effects and Pharmacological Impact of Intracerebroventricular Insulin Administration in Mice
Alexandre P. Muller et al.
HIPPOCAMPUS (2011)
The neuroprotective role of boric acid on aluminum chloride-induced neurotoxicity
Suat Colak et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2011)
The bile acid sensor FXR regulates insulin transcription and secretion
Barbara Renga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease
J. R. Walton et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter
Hong Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2008)
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Wei-Qin Zhao et al.
FASEB JOURNAL (2008)
Novel potent and selective bile acid derivatives as TGR5 agonists: Biological screening, structure-activity relationships, and molecular modeling studies
Hiroyuki Sato et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Intermittent ethanol exposure induces inflammatory brain damage and causes long-term behavioural alterations in adolescent rats
Maria Pascual et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Charles V. Vorhees et al.
NATURE PROTOCOLS (2006)
Cross-talk between farnesoid-X-receptor (FXR)and peroxisome proliferator-activated receptor γ contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Behavioural effects of dimethyl sulfoxide (DMSO):: Changes in sleep architecture in rats
M Cavas et al.
TOXICOLOGY LETTERS (2005)
The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion
JL Lew et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Accumulation of aluminum in rat brain - Does it lead to behavioral and electrophysiological changes?
T Baydar et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2003)
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action
V Aguirre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review
JM Malinowski et al.
CLINICAL THERAPEUTICS (2000)